| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |